If you happen to be in the market for a small artificial sun, you may be interested to know that for about $1300, you can get a tennis-ball-sized LED array that outputs 120,000 lumens.

Motorola's new Razr Fold is coming soon, and the software has been revealed with an in-between of Google Pixel and Samsung Galaxy.

Google has confirmed preparation for Android 17, with the beta starting soon and full software expected to roll out in June 2026. The beta programme will give developers access to new core features to ...

Feb 10 (Reuters) - Concerns that artificial ‌intelligence could disrupt large parts ‌of the software industry have started to spill into credit markets, Morgan Stanley warned, as software accounts for ...

Nvidia (NVDA) led chip stock higher on Friday after the broader market saw gains after several days of technology-led selloffs, especially in the software sector. The tech-focused Nasdaq Composite ...

Google Pixel phones stand out among Android devices for combining clean software, fast updates, and AI-powered tools that other brands often implement later or not at all. The Pixel Android experience ...

IT stocks globally have been under pressure for months, due to fears of AI affecting future business growth. The latest crash in prices comes on the back of Anthropic rolling out new legal tools for ...

Software shares plunged on Thursday, even after some of the biggest names in the industry reported positive earnings. Microsoft (MSFT) was at the forefront of the trend, with the stock dropping ...

Google Pixel phones are notorious for having hidden settings that can greatly enhance the user experience. The list includes options for ramping up the display refresh rate, optimizing the battery ...

The P600R Hard P4 and P1200R Hard P8 balance 600W and 1200W of legitimate punch with 4- and 8-zone pixel control, as well as instant hard-to-soft diffusion that doesn't kill your color consistency.

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program designed to help patients navigate the decision between semaglutide and tirzepatide, ...